Key result
ACE inhibition decreases renal perfusion only in patients with glomerular diseases.
Why the study?
The acute and chronic effects of ACE inhibition on renal and glomerular haemodynamics in glomerular versus interstitial nephropathies were uncertain.
Does enalapril or ramipril alter renal haemodynamics in hypertensive patients with non-diabetic nephropathies?
Does enalapril or ramipril alter renal haemodynamics in hypertensive patients with non-diabetic nephropathies?
ACE inhibition alters renal haemodynamics acutely and chronically only in patients with glomerular diseases, not interstitial nephropathies.
BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors are the drugs of choice for the treatment of hypertension in patients with non-diabetic nephropathies. However, not every trial has reported better results with ACE inhibitors (ACE-I) than with other drugs. This study investigates whether the acute and chronic effects of ACE inhibition on renal and glomerular haemodynamics are similar in glomerular and interstitial nephropathies. METHODS: We studied 20 hypertensive patients, on their usual diet, with mild-to-moderate chronic renal failure secondary to non-diabetic nephropathy. After a three-week wash out period, we determined plasma clearances of para-amino-hippurate and inulin before, and after acute oral administration of either enalapril or ramipril. This same test was carried out after one and two years of treatment with the same drug. RESULTS: Acute ACE inhibition causes a decrease of renal perfusion, glomerular filtration and pressure with an increase of afferent resistances. Long-term ACE inhibition is associated only with a decrease in renal perfusion, with a non-significant tendency to higher filtration fraction and lower afferent resistances. All the renal haemodynamic modifications mentioned above are present only in patients with glomerular diseases. CONCLUSIONS: Renal and glomerular haemodynamic responses are not similar after acute and chronic ACE inhibition. Only patients with glomerular diseases show acute or long-term responses to ACE inhibition.
No takes yet. Share an insight, caveat, or question.
Guidi et al. (2002) studied Hypertension with mild-to-moderate chronic renal failure secondary to non-diabetic nephropathy (n=20). ACE inhibitors (enalapril or ramipril) vs. Baseline was evaluated on Renal and glomerular haemodynamics (plasma clearances of para-amino-hippurate and inulin). Acute and long-term ACE inhibition altered renal haemodynamics, including decreased renal perfusion, only in patients with glomerular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: